
FDA's Vision Warning On Ozempic Lands As 2027 ACA Premiums Climb Again
Federal regulators flagged a possible vision loss risk tied to Ozempic, Wegovy and Zepbound — and the same week, 2027 ACA premiums are set to jump. Here's what our families need to know.




